Sotuvning operatsion marjasi: Immatics NV (IMTX)

Immatics Biotechnologies (IMTX) kompaniyasining korporativ logotipi

Immatics N.V. global biotexnologiya gigantlari bilan hamkorlikda shaxsiylashtirilgan terapiya usullarini ishlab chiqmoqda. GURU.Markets platformasidagi asosiy biznes marjalarining o'zgarishi joriy aktivlar dinamikasini aks ettiradi, bunda -588.50 eng so'nggi baholash metrikani belgilaydi. Istiqbollar IMA203 platformasining muvaffaqiyati va hamkorlarning qo'llab-quvvatlashiga bog'liq, qattiq o'smalar uchun innovatsion dori portfeli esa endigina o'z hayot siklini boshlamoqda.

IMTX: immatics.com Operatsion foyda normasi 04.07.2022 - 19.11.2026

Immatics N.V. - tahliliy kesimlar va asosiy koʻrsatkichlar (IMTX)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:IMTX, Immatics
Immatics Biotechnologies asosiy tovari

Portfel tahlilchisi biofarmatsevtika sektoridagi fundamental yetakchilarni saralash uchun ushbu ko'rsatkichdan foydalanadi. Ushbu metrika operatsion foydaning umumiy daromadga nisbati sifatida hisoblanadi va moliyaviy majburiyatlar hisobga olinishidan oldingi xarajatlarni boshqarish samaradorligini o'lchaydi. Immatics N.V. (IMTX) uchun ushbu hisob-kitob T-hujayra terapiyalarini ishlab chiqish xarajatlarining joriy daromadlar nisbatini aks ettiradi. Yuqori klinik tasdiqlash xarajatlari ko'pincha operatsion daromadning daromadga nisbatining salbiy bo'lishiga olib keladi. Ushbu ko'rsatkichning tendentsiyasi kompaniyaning zararsiz nuqtaga yetish sur'atlarini baholash imkonini beradi.

Immatics N.V. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Xencor Inc.|Compass Therapeutics (CMPX) - Operatsion rentabellik|Replimune Group, Inc. - Operatsion foyda normasi|LYEL (lyell.com) - Operatsion marja|Operatsion marja Innate Pharma SA|Operatsion rentabellik pyxisoncology.com (PYXS)|CGEN: Operatsion foyda marjasi|IO Biotech Inc - Sotuvning operatsion marjasi|sutrobio.com (STRO) - Sotuvning operatsion rentabelligi|INKT - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja